Skip to main content
Clinical Trials/ISRCTN23620802
ISRCTN23620802
Completed
N/A

An interventional study to investigate the effect of riboflavin supplementation (1.6mg/d/16weeks) on blood pressure in hypertensive individuals who are homozygous for the 677Câ T polymorphism (TT genotype) in the gene encoding the enzyme methylenetetrahydrofolate reductase (MTHFR)

niversity of Ulster (UK)0 sites80 target enrollmentFebruary 2, 2012

Overview

Phase
N/A
Intervention
Not specified
Conditions
Hypertension
Sponsor
niversity of Ulster (UK)
Enrollment
80
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 2, 2012
End Date
TBD
Last Updated
9 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversity of Ulster (UK)

Eligibility Criteria

Inclusion Criteria

  • 1\. Individuals recruited previously who consented to being contacted regarding future studies
  • 2\. Individuals identified as having the TT genotype

Exclusion Criteria

  • 1\. A history of gastrointestinal, hepatic, renal or haematological disorders
  • 2\. Are taking B vitamin supplements, anticonvulsant therapy or any other drugs known to interfere with folate / B vitamin metabolism

Outcomes

Primary Outcomes

Not specified

Similar Trials